Biotech
TAHO Pharma
Pipelines & Platforms
- Transdermal / Transmucosal platforms:
505 (b) (2):- TAH3311 - Apixaban ODF
- TAH3341 - ER Apixaban ODF
- TAH0031 - Nintedanib buccal film
- TAH4411 - Ondansetron ODF
- TAH9901 - Methylphenidate patch
- TAH2211 - Buprenorphine/Naloxone sublingual film
Interests
- Out-licensing
- Co-development
Contact Information
- NameKiki Hsu
- PositionAssociate BD Manager
- Tel+886-2-2659-8515 #1207
- Emailkikihsu@tahopharma.com
- https://www.tahopharma.com/en/